Testing effectiveness (Phase 2)Study completedNCT04663737
What this trial is testing
Evaluating Safety, Pharmacokinetics and Clinical Benefit of Silmitasertib (CX-4945) in Subjects With Moderate COVID-19
Who this might be right for
Covid19
Senhwa Biosciences, Inc. 20